JPH04230357A - 硫黄置換メビン酸誘導体 - Google Patents

硫黄置換メビン酸誘導体

Info

Publication number
JPH04230357A
JPH04230357A JP3165683A JP16568391A JPH04230357A JP H04230357 A JPH04230357 A JP H04230357A JP 3165683 A JP3165683 A JP 3165683A JP 16568391 A JP16568391 A JP 16568391A JP H04230357 A JPH04230357 A JP H04230357A
Authority
JP
Japan
Prior art keywords
methyl
decahydro
acid
dihydroxy
dimethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP3165683A
Other languages
English (en)
Japanese (ja)
Inventor
Ravi K Varma
ラビ・ケイ・バルマ
Jeffrey O Saunders
ジェフリー・オー・ソーンダーズ
Sam T Chao
サム・ティ・チャオ
Eric M Gordon
エリック・エム・ゴードン
Dinos P Santafianos
ディノス・ピー・サンタフィアノス
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Co
ER Squibb and Sons LLC
Original Assignee
Bristol Myers Squibb Co
ER Squibb and Sons LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co, ER Squibb and Sons LLC filed Critical Bristol Myers Squibb Co
Publication of JPH04230357A publication Critical patent/JPH04230357A/ja
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/20—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hydrogen atoms and substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D309/22—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/64—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and sulfur atoms, not being part of thio groups, bound to the same carbon skeleton
    • C07C323/65—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and sulfur atoms, not being part of thio groups, bound to the same carbon skeleton containing sulfur atoms of sulfone or sulfoxide groups bound to the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
    • C07C317/46—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton the carbon skeleton being further substituted by singly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/61—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a ring other than a six-membered aromatic ring of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)
JP3165683A 1990-07-06 1991-07-05 硫黄置換メビン酸誘導体 Withdrawn JPH04230357A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US54902490A 1990-07-06 1990-07-06
US549,024 1990-07-06

Publications (1)

Publication Number Publication Date
JPH04230357A true JPH04230357A (ja) 1992-08-19

Family

ID=24191347

Family Applications (1)

Application Number Title Priority Date Filing Date
JP3165683A Withdrawn JPH04230357A (ja) 1990-07-06 1991-07-05 硫黄置換メビン酸誘導体

Country Status (20)

Country Link
EP (1) EP0465265A1 (en:Method)
JP (1) JPH04230357A (en:Method)
KR (1) KR920002571A (en:Method)
CN (1) CN1058585A (en:Method)
AU (1) AU647492B2 (en:Method)
CA (1) CA2046171A1 (en:Method)
CS (1) CS207191A3 (en:Method)
FI (1) FI913285A7 (en:Method)
HU (1) HUT58682A (en:Method)
IE (1) IE912312A1 (en:Method)
IL (1) IL98721A0 (en:Method)
MX (1) MX9100095A (en:Method)
MY (1) MY106564A (en:Method)
NO (1) NO912636L (en:Method)
NZ (1) NZ238848A (en:Method)
PL (2) PL290954A1 (en:Method)
PT (1) PT98246A (en:Method)
RU (1) RU2041205C1 (en:Method)
TW (1) TW227552B (en:Method)
ZA (1) ZA915171B (en:Method)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5369123A (en) * 1992-10-09 1994-11-29 E. R. Squibb & Sons, Inc. Nitrogen-substituted mevinic acid derivatives useful as HMG-CoA reductase inhibitors
US6043064A (en) * 1993-10-22 2000-03-28 Bristol-Myers Squibb Company Enzymatic hydroxylation process for the preparation of HMG-CoA reductase inhibitors and intermediates thereof
GB2329334A (en) * 1997-09-18 1999-03-24 Reckitt & Colmann Prod Ltd Cholesterol-lowering agents
US20210008084A1 (en) 2017-10-16 2021-01-14 Tsinghua University Mevalonate pathway inhibitor and pharmaceutical composition thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT88364A (pt) * 1987-09-02 1989-07-31 Merck & Co Inc Process for preparing novel hmg-coa reductase inhibitors
US4866090A (en) * 1988-01-07 1989-09-12 Merck & Co., Inc. Novel HMG-CoA reductase inhibitors
FI893004L (fi) * 1988-06-29 1989-12-30 Merck & Co Inc 5-oxygenerade hmg-coa-reduktas -inhibitorer.
EP0415488B1 (en) * 1989-08-31 1994-04-20 Merck & Co. Inc. 7-Substituted HMG-COA reductase inhibitors

Also Published As

Publication number Publication date
CS207191A3 (en) 1992-04-15
TW227552B (en:Method) 1994-08-01
HUT58682A (en) 1992-03-30
IE912312A1 (en) 1992-01-15
ZA915171B (en) 1992-06-24
FI913285A0 (fi) 1991-07-05
EP0465265A1 (en) 1992-01-08
MX9100095A (es) 1992-02-28
NO912636L (no) 1992-01-07
PT98246A (pt) 1992-05-29
CA2046171A1 (en) 1992-01-07
KR920002571A (ko) 1992-02-28
CN1058585A (zh) 1992-02-12
PL295149A1 (en) 1992-11-30
IL98721A0 (en) 1992-07-15
HU912287D0 (en) 1991-12-30
AU647492B2 (en) 1994-03-24
NO912636D0 (no) 1991-07-05
NZ238848A (en) 1993-06-25
RU2041205C1 (ru) 1995-08-09
AU8012091A (en) 1992-01-09
FI913285A7 (fi) 1992-01-07
MY106564A (en) 1995-06-30
PL290954A1 (en) 1992-11-16

Similar Documents

Publication Publication Date Title
KR890000622B1 (ko) 5-히드록시-6-티오-치환 알칸산 유도체의 제조방법
KR101478593B1 (ko) 미생물에 의해 매개되는 질병 치료용 플루로뮤틸린 유도체
HU215604B (hu) Eljárás biológiailag hatásos 19-nor-D-vitamin-vegyületek és ilyen vegyületeket tartalmazó gyógyászati készítmények előállítására
JPH04506965A (ja) 新規ビタミンｄ類似体
WO1995001326A1 (en) Anti-atherosclerotic diaryl compounds
Rosen et al. Synthetic and biological studies of compactin and related compounds. 2. Synthesis of the lactone moiety of compactin
JPH04230357A (ja) 硫黄置換メビン酸誘導体
US6362218B1 (en) Brefeldin A derivatives
AU755701B2 (en) Method for making hydroxy-25-ene-vitamin D compounds
JPH0449543B2 (en:Method)
US5177104A (en) 6-α-hydroxy derivatives of mevinic acids
US5264455A (en) Sulfur-substituted mevinic acid derivatives
US5089523A (en) Fluorinated derivatives of mevinic acids
ES2396524A1 (es) Intermedios versátiles y funcionalizados en la síntesis de vitamina D y nuevos derivados de vitamina D
EP0338796A2 (en) 2-Substituted-2-cyclopentenones
US5286746A (en) Sulfur-substituted mevinic acid derivatives
JPH11500112A (ja) 新規のボルネオール誘導体、その製造方法及び薬剤学的使用
CA2354516A1 (en) Hydronaphtho[2,3-c]furan derivatives and process for the preparation thereof
EP0454494A2 (en) Calicheamicinone, derivatives and analogs thereof and methods of making the same
Castellanos et al. Oxidative reactions of sulfinyl dienes as an entry to functionalized carbohydrate-like products and furans
JPH09512799A (ja) チューブリン重合及び解重合に影響を与えるボルネオール誘導体
Frischmuth et al. Strigol synthetic studies the problem of stereocontrol at C-2′
EP1219599B1 (en) Vitamin d derivatives having substituents at the 2 alpha-position
Subramanyam et al. Building block approach for the convenient synthesis of resorcinol alkyl C-glucoside
WO1996026891A1 (fr) Derives de cyclopentene substitues et leur procede de preparation

Legal Events

Date Code Title Description
A300 Application deemed to be withdrawn because no request for examination was validly filed

Free format text: JAPANESE INTERMEDIATE CODE: A300

Effective date: 19981008